You are here: Industry Insights > immune response

News List

Delaying second dose of mRNA COVID-19 vaccine produces stronger immune response WorldPharmaNews
December 02, 2021
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada...
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing prnasia
May 19, 2021
Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ...
Serimmune Opens Enrollment for COVID-19 Immune Response Study prnewswire
April 14, 2021
Serimmune, Inc. announced that the company is enrolling 2,000 research participants in a study designed to understand the human immune response to SARS-CoV-2, the virus that causes COVID-19.
Scottish COVID-19 vaccine shows ‘strong immune response’ in early UK trials expresspharma
April 08, 2021
The vaccine, called VLA2001, also induced T-cell responses, which help the body fend off a virus and determine long-lasting immunity.
New findings help explain how COVID-19 overpowers the immune system worldpharmanews
January 13, 2021
Seeking to understand why COVID-19 is able to suppress the body's immune response, new research from the USC Leonard Davis School of Gerontology suggests that mitochondria are one of the first lines of defense against COVID-19 and identifies key ...
DPX-COVID-19 has potential to improve duration of immune response expresspharma
October 21, 2020
On October 8, Canada-based biotech company, IMV, which is soon to publish pre-clinical data on DPX-COVID-19, its immunotherapy-based vaccine candidate for the prevention of SARS-COV-2, announced that to increase its current manufacturing capacity ...
J&J COVID-19 vaccine candidate yields strong immune response in early trial expresspharma
September 27, 2020
Immune response results were available from only 15 people over 65 years old, limiting the interpretation.
Which immune response could cause a vaccine against COVID-19? worldpharmanews
September 15, 2020
Immune reactions caused by vaccination can help protect the organism, or sometimes may aggravate the condition. It is especially important now when multiple vaccines against COVID-19 are being developed.
Further £8.4 million in funding given to UK researchers studying immune response to COVID-19 europeanpharmaceuticalreview
August 31, 2020
The funding is being split across three research projects that will hopefully improve the treatment of COVID-19 and inform the development of vaccines and therapeutics.
University of Sheffield joins UK Coronavirus Immunology Consortium for COVID-19 research expresspharma
August 31, 2020
The Sheffield team will investigate how the body’s immune system responds to infection and also examine how T cells contribute to immunity to the virus to prevent re-infection.

Previous page 1 2 Next page